Usefulness of fragile X checklist and CGG distribution in specialized institutions in Kinshasa, DR Congo
- PMID: 29974402
- PMCID: PMC6325043
- DOI: 10.1007/s12687-018-0374-4
Usefulness of fragile X checklist and CGG distribution in specialized institutions in Kinshasa, DR Congo
Abstract
Screening for fragile X syndrome (FXS) is essential in children with developmental delay or intellectual disability (ID). In addition, using clinical screening checklists remains of high interest in resource-limited settings. We aimed to gain insight into the prevalence of FXS and the distribution of CGG alleles and to evaluate the usefulness of three checklists in specialized institutions in Kinshasa, DR Congo. We recruited 80 males and 25 females from six specialized institutions in Kinshasa and administered a questionnaire comprising items from the following FXS checklists: Hagerman, Maes, and Guruju. FMR1 CGG repeats were assessed for every patient. About 37% of patients were referable for FX testing based on Hagerman's checklist, 35% for Maes', and 43.80% for Guruju's, but none of them was molecularly confirmed to have FXS. Thus, specificities were 62.86, 64.76, and 56.5%, respectively, for Hagerman, Maes, and Guruju, respectively. The mean CGG allele size was 28.55 ± 2.83 (ranges, 17-48). The 29 CGG was the most frequent allele (24.61%). Thus, existing checklists should not be automatically applied to Congolese patients without adjustments. The distribution of CGG repeats and the number of CGG alleles are similar to other African studies.
Keywords: Behavioral manifestation; Checklist; Democratic Republic of Congo; Dysmorphism; Fragile X syndrome.
Conflict of interest statement
Conflict of interest
The authors declare that they have no conflict of interest.
Figures




Similar articles
-
FMR1 gene CGG repeat distribution among the three individual cohorts with intellectual disability, autism, and primary ovarian insufficiency from Tamil Nadu, Southern India.Adv Genet (Hoboken). 2021 May 28;2(2):e10048. doi: 10.1002/ggn2.10048. eCollection 2021 Jun. Adv Genet (Hoboken). 2021. PMID: 36618123 Free PMC article.
-
Fragile X spectrum disorders.Intractable Rare Dis Res. 2014 Nov;3(4):134-46. doi: 10.5582/irdr.2014.01022. Intractable Rare Dis Res. 2014. PMID: 25606363 Free PMC article. Review.
-
An assessment of screening strategies for fragile X syndrome in the UK.Health Technol Assess. 2001;5(7):1-95. doi: 10.3310/hta5070. Health Technol Assess. 2001. PMID: 11262423 Review.
-
Molecular analysis of fragile X syndrome (FXS) among Malaysian patients with developmental disability.Malays J Pathol. 2017 Aug;39(2):99-106. Malays J Pathol. 2017. PMID: 28866690
-
CGG-repeat dynamics and FMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons.Mol Autism. 2016 Oct 6;7:42. doi: 10.1186/s13229-016-0105-9. eCollection 2016. Mol Autism. 2016. PMID: 27713816 Free PMC article.
Cited by
-
Cascade Testing for Fragile X Syndrome in a Rural Setting in Cameroon (Sub-Saharan Africa).Genes (Basel). 2020 Jan 28;11(2):136. doi: 10.3390/genes11020136. Genes (Basel). 2020. PMID: 32012997 Free PMC article.
-
A Comprehensive Review of Fragile X Syndrome and Fragile X Premutation Associated Conditions in Africa.Genes (Basel). 2024 May 25;15(6):683. doi: 10.3390/genes15060683. Genes (Basel). 2024. PMID: 38927619 Free PMC article. Review.
References
-
- Behery AK. Fragile x-syndrome: clinical and molecular studies. J Egypt Public Health Assoc. 2008;83:273–283. - PubMed
-
- Crawford DC, Acuna JM, Sherman SL (2001) FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 3:359–371. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493892/ - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources